BrightEdge is a venture capital firm that invests in the cancer research institute.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
BrightEdge is a venture capital firm that invests in the cancer research institute.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2021 | TailorMed | Venture Round | 0 |
2/2023 | Thatch | Seed Round | 0 |
9/2019 | Navigating Cancer | Series D | 0 |
8/2020 | Freenome | Series C | 270M |
11/2021 | Alpheus Medical | Series A | 0 |
8/2021 | Immunitas Therapeutics | Series B | 0 |
9/2022 | Naveris | Series A | 33.4M |
12/2021 | Freenome | Series D | 300M |
7/2022 | Auron Therapeutics | Series A | 0 |
6/2020 | Checkmate Pharmaceuticals | Series C | 85M |
11/2022 | Alpheus Medical | Series A | 14M |
7/2022 | Persephone Biosciences | Seed Round | 0 |
10/2019 | Tmunity Therapeutics | Series B | 0 |
1/2023 | Paradigm | Series A | 0 |
4/2019 | Castle Biosciences | Convertible Note | 12M |
1/2021 | Auron Therapeutics | Seed Round | 0 |
5/2021 | Interius BioTherapeutics | Series A | 0 |
1/2022 | CellCentric | Venture Round | - |
10/2022 | Vincere Health | Seed Round | 0 |
9/2022 | Meliora Therapeutics | Seed | 11M |
7/2022 | Auron Therapeutics | Series A | 0 |
7/2022 | Persephone Biosciences | Seed Round | 0 |
1/2022 | CellCentric | Venture Round | - |
12/2021 | Freenome | Series D | 0 |
11/2021 | Alpheus Medical | Series A | 0 |
9/2021 | TailorMed | Venture Round | 0 |
8/2021 | Immunitas Therapeutics | Series B | 0 |
5/2021 | Interius BioTherapeutics | Series A | 0 |
1/2021 | Auron Therapeutics | Seed Round | 0 |
8/2020 | Freenome | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|